Dr. Shehneela Dar (MD), USMLE

Director, Medical Research (Volunteer)

Canadian Journal of Scientific and Clinical Discovery (CJSCD)

Toronto, Canada

 Professional Biography

Dr. Shehneela Dar serves as the Director of Medical Research (Volunteer) at "the Canadian Journal of Scientific and Clinical Discovery (CJSCD)" based in Toronto, Canada. Her work spans several critical domains of clinical science, with a strong focus on cardiology, diabetes, hypertension, and polycystic kidney disease. Dr. Dar’s research emphasizes the integration of molecular insights with clinical practice, advancing early diagnostic strategies, innovative therapeutic approaches, and long‑term patient outcome improvement. Through her leadership at CJSCD, she contributes to strengthening scientific rigor, fostering interdisciplinary collaboration, and promoting high‑impact clinical research within the global medical community.

Research Profile

Dr. Dar’s research program centers on the intersection of cardiovascular medicine, metabolic disorders, and renal pathophysiology. Her work employs translational approaches that bridge fundamental biological mechanisms with clinical application. She is particularly engaged in identifying early diagnostic markers, evaluating emerging therapeutic strategies, and improving long‑term outcomes for patients with chronic cardio-metabolic and renal conditions. Her contributions support evidence‑based clinical practice and advance interdisciplinary scientific discovery.

Clinical Interests

Cardiology

 .           Management of heart failure, arrhythmias, and ischemic heart disease.

 •           Preventive cardiology with emphasis on risk‑factor modification and patient‑centered care.

Diabetes

•           Clinical management of Type 1 and Type 2 diabetes.

•           Metabolic dysregulation and insulin resistance.

•           Prevention of diabetes‑related cardiovascular and renal complications.

Hypertension

•           Diagnosis and long‑term management of hypertension.

•           Mechanisms of blood pressure regulation.

•           Vascular remodelling in hypertensive populations.

Polycystic Kidney Disease (PKD)

•           Early detection and renal function preservation.

•           Clinical monitoring of PKD progression.

•           Integration of genetic and molecular insights into patient care.

Scholarly Focus

•           Molecular and physiological mechanisms underlying cardio-metabolic diseases.

•           Transnational research linking laboratory findings to clinical interventions.

•           Development and evaluation of novel diagnostic and therapeutic modalities.

•           Longitudinal studies on disease progression in diabetes, hypertension, and PKD.

•           Interdisciplinary collaboration across cardiology, nephrology, and metabolic medicine

•           Advancement of clinical research methodologies within scientific and peer‑reviewed publishing